PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 6:38 AM ET

Sponsor Check › Person

JT
No photo found yet (own website and image search run after this page is viewed)

Jim Tananbaum

Named as an officer, director or promoter on SEC Form D filings · CA, MA · Jul 2, 2013 → Feb 13, 2025

6deals (issuers)
$279.1Mreported sold
67investors
9Form D filings
2013–2025years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:29 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Jim Tananbaum is listed as a director on 9 SEC Form D filings by 6 issuers between Jul 2013 and Feb 2025. Largest by amount reported sold: Kinnate Biopharma Inc. (San Diego, CA — biotechnology — 2020; $98M reported sold to 24 investors), LifeMine Therapeutics, Inc. (Cambridge, MA — biotechnology — 2017; $70.1M reported sold to 10 investors), Latigo Biotherapeutics, Inc. (Thousand Oaks, CA — biotechnology — 2025; $50M reported sold to 7 investors), Mindstrong, Inc. (Palo Alto, CA — other technology — 2017–2018; $31M reported sold to 8 investors), Sequenta, Inc. (South San Francisco, CA — industry reported as "Other" — 2013; $20M reported sold to 14 investors) and 1 more (all listed below).

What this means A repeat sponsor — 6 separate companies raised money with this person listed as director, over about 12 years. Across those companies the filings report $279.1M sold in total.

Listed alongside Richard Klausner (4 shared filings), Nima Farzan (3 shared filings), Paul Dagum (3 shared filings), Carl L. Gordon (2 shared filings), Keith Flaherty (2 shared filings) and 30 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jim. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 9 public filings for Jim Tananbaum and found 9 differences, 1 worth asking the sponsor about: Jim Tananbaum is no longer listed on the Mar 29, 2019 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Jim Tananbaum has not run yet — it is joining a line of 20,016 names; searches run around the clock at the hosts' allowed rate. Searched so far: 80 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:29 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: NV (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Jim Tananbaum..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for IA, IN, KS, MI, NE, NV (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:29 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

9 differences found between the filings for Jim Tananbaum — 1 worth asking about (compared 9 filings on Oct 24, 2026)

Note · Nov 7, 1994 – Nov 18, 2010

4 bankruptcy cases name the subject or team members

Bankruptcy case: Meltz v. GMAC MORTGAGE, L..L.C., DBA DITECH.COM — filed Jul 2, 2010 · Bankruptcy case: First USA Bank, N.A. v. Seidenberg — filed Nov 18, 1999 · Bankruptcy case: Tim Lugo — filed May 6, 1997 · Bankruptcy case: Transamerica Financial Professional Serv v. Meltz — filed Nov 7, 1994

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Sources
Note · Jan 28, 2025 – Feb 13, 2025

Form D filed 16 days after the first sale — Latigo Biotherapeutics, Inc.

The filing says the first sale was Jan 28, 2025. The Form D was filed Feb 13, 2025 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jan 28, 2025 – Feb 13, 2025

No amendment in the last 12 months on an offering that may still be open — Latigo Biotherapeutics, Inc. (latest filing Feb 13, 2025)

The latest filing for this offering is dated Feb 13, 2025 (first sale Jan 28, 2025). It reports $49,999,995 sold of $149,999,990 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Feb 27, 2017 – Mar 9, 2017

No amendment in the last 12 months on an offering that may still be open — Mindstrong, Inc. (latest filing Mar 9, 2017)

The latest filing for this offering is dated Mar 9, 2017 (first sale Feb 27, 2017). It reports $8,600,000 sold of $14,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Worth asking · Sep 27, 2017 – Mar 29, 2019

Jim Tananbaum is no longer listed on the Mar 29, 2019 amendment — LifeMine Therapeutics, Inc.

Jim Tananbaum appears on the Sep 27, 2017 Form D (director) but not on the Mar 29, 2019 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Aug 4, 2020 – Aug 31, 2020

Offering amount changed between filings — Kinnate Biopharma Inc.

The Aug 4, 2020 filing says $87,999,943 offered; the Aug 31, 2020 Form D/A says $97,999,937.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Sep 27, 2017 – Mar 29, 2019

Offering amount changed between filings — LifeMine Therapeutics, Inc.

The Sep 27, 2017 filing says $55,074,132 offered; the Mar 29, 2019 Form D/A says $70,074,079.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Mar 9, 2017 – Jun 14, 2018

Address moved from Mountain View, CA to Palo Alto, CA — Mindstrong, Inc.

The people listed on the Mar 9, 2017 filing give Mountain View, CA; on the Jun 14, 2018 filing they give Palo Alto, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Jul 2, 2013 – Feb 13, 2025

Jim Tananbaum is listed with 2 different address states: CA, MA

CA on 8 filings (Jul 2, 2013 to Feb 13, 2025); MA on 1 filing (Sep 27, 2017).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 8 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Feb 13, 2025 D
Latigo Biotherapeutics, Inc.
File 021-538236
$0$0$0None listed on this filingEDGAR ↗
May 13, 2021 D
Seranova Bio, Inc.
File 021-399247
$0$0$0
No amounts other than ordinary course employment compensation is being paid to officers and managers.
None listed on this filingEDGAR ↗
Aug 31, 2020 D/A
Kinnate Biopharma Inc.
File 021-372487
$0$0$0None listed on this filingEDGAR ↗
Dec 21, 2018 D
Mindstrong, Inc.
File 021-328766
$0$0$0None listed on this filingEDGAR ↗
Jun 14, 2018 D
Mindstrong, Inc.
File 021-314614
$0$0$0None listed on this filingEDGAR ↗
Sep 27, 2017 D
LifeMine Therapeutics, Inc.
File 021-295461
$0$0$0None listed on this filingEDGAR ↗
Mar 9, 2017 D
Mindstrong, Inc.
File 021-282094
$0$0$0None listed on this filingEDGAR ↗
Jul 2, 2013 D
Sequenta, Inc.
File 021-198961
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 6

Every issuer that named Jim Tananbaum on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Latigo Biotherapeutics, Inc.

Thousand Oaks, CA · Feb 13, 2025
  • Feb 13, 2025 · D · $49,999,995 sold of $149,999,990 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 7 investors (33% of the $150M target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Seranova Bio, Inc.

South San Francisco, CA · May 13, 2021
  • May 13, 2021 · D · $5,049,990 sold of $5,049,990 · 2 investors · min. No minimum reported · role: Director (Manager) EDGAR ↗

Raised $10M from 4 investors (100% of the $5.05M target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Kinnate Biopharma Inc.

San Diego, CA · Aug 4, 2020 → Aug 31, 2020 · 2 filings
  • Aug 31, 2020 · D/A · $97,999,937 sold of $97,999,937 · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 4, 2020 · D · $87,999,943 sold of $87,999,943 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $98M from 24 investors (100% of the $98M target) as of the latest filing. Jim is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Technology

Mindstrong, Inc.

Palo Alto, CA · Mar 9, 2017 → Dec 21, 2018 · 3 filings
  • Dec 21, 2018 · D · $30,998,704 sold of $30,998,704 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 14, 2018 · D · $12,366,810 sold of $12,366,810 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 9, 2017 · D · $8,600,000 sold of $14,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $31M from 8 investors (100% of the $31M target) as of the latest filing. Jim is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

LifeMine Therapeutics, Inc.

Cambridge, MA · Sep 27, 2017
  • Sep 27, 2017 · D · $25,074,131 sold of $55,074,132 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $70.1M from 10 investors (100% of the $55.1M target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

Sequenta, Inc.

South San Francisco, CA · Jul 2, 2013
  • Jul 2, 2013 · D · $20,000,001 sold of $20,000,001 · 12 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20M from 14 investors (100% of the $20M target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Jim 35

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Klausner

Director, Promoter · 4 shared filings (2 issuers) · also on 6 other issuers

Richard Klausner is on 8 issuers in total — a repeat sponsor. Their page lists every one.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Dagum

Executive Officer, Director, Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

NF
No photo found yet (own website and image search run after this page is viewed)
Person

Nima Farzan

Executive Officer, Director · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

TI
No photo found yet (own website and image search run after this page is viewed)
Person

Tom Insel

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 2 shared filings (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen W. Kaldor

Director, Promoter · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Rome

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Keith Flaherty

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Meltz

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

GV
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory L. Verdine

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dean Mitchell

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Nancy Stagliano

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Beth Seidenberg

Director · 1 shared filing (1 issuer) · also on 28 other issuers

Beth Seidenberg is on 29 issuers in total — a repeat sponsor. Their page lists every one.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Malek Faham

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Willis

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

BE
No photo found yet (own website and image search run after this page is viewed)
Person

Bill Ericson

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

KY
No photo found yet (own website and image search run after this page is viewed)
Person

Krishna Yeshwant

Director · 1 shared filing (1 issuer) · also on 9 other issuers

Krishna Yeshwant is on 10 issuers in total — a repeat sponsor. Their page lists every one.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Karen Kirk

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

EG
No photo found yet (own website and image search run after this page is viewed)
Person

Ephraim Gildor

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

RE
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Epstein

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Robert Epstein is on 5 issuers in total — a repeat sponsor. Their page lists every one.

WZ
No photo found yet (own website and image search run after this page is viewed)
Person

WeiQing Zhou

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

HH
No photo found yet (own website and image search run after this page is viewed)
Person

Hingge Hsu

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

John R. Stuelpnagel

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

EH
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Hu

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

YC
No photo found yet (own website and image search run after this page is viewed)
Person

Yanling Cao

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Aaron Ring

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Klasko

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

Sarah London

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

KR
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Raidy

Director · 1 shared filing (1 issuer) · also on 8 other issuers

Kevin Raidy is on 9 issuers in total — a repeat sponsor. Their page lists every one.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Beatrice McQueen

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

LA
No photo found yet (own website and image search run after this page is viewed)
Person

Laurie Smaldone Alsup

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Deborah Palestrant

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Tim Lugo

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Tim Walbert

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Tananbaum. Their page shows their other deals.

HT
No photo found yet (own website and image search run after this page is viewed)
Person

Hemant Taneja

Director · 1 shared filing (1 issuer) · also on 82 other issuers

Hemant Taneja is on 83 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Same business address

3 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 6 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Jim Tananbaum by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 6 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Jim Tananbaum is listed on: none on file. No website or social profile named in Kinnate Biopharma Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #210,925 of 374,652 in line (158 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Jim Tananbaum appears on a new Form D, or when a court case or SEC action is matched to them. See plans →